Testing effectiveness (Phase 2)Ended earlyNCT01061580What this trial is testingBMAC Enhanced Coronary Artery Bypass Grafting (CABG)Who this might be right forCongestive Heart Failure Harvest Technologies 20
Testing effectiveness (Phase 2)UnknownNCT02709876What this trial is testingAutologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis PigmentosaWho this might be right forRetinitis Pigmentosa Stem Cells Arabia 50
Testing effectiveness (Phase 2)Study completedNCT02500550What this trial is testingSafety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical DonorWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome Kiadis Pharma 15
Testing effectiveness (Phase 2)Ended earlyNCT00720850What this trial is testingLenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)Who this might be right forMyelodysplastic SyndromesAcute Myelogenous Leukemia Technische Universität Dresden 10
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Testing effectiveness (Phase 2)Study completedNCT00750659What this trial is testingNilotinib Pre and Post Allogeneic Stem Cell TransplantationWho this might be right forChronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaStem Cell Transplantation Sheba Medical Center 24
Early research (Phase 1)Study completedNCT00005946What this trial is testingChemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell TransplantationWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT00578942What this trial is testingAllo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using CampathWho this might be right forLymphomaMyelomaLeukemia+2 more David Rizzieri, MD 48
Very early researchUnknownNCT03248466What this trial is testingPRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot UlcerWho this might be right forDiabetic Foot Ulcer Third Military Medical University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06529731What this trial is testingInterferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell TransplantationWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes Sawa Ito, MD 45
Not applicableUnknownNCT04476550What this trial is testingClinical Specimen Collection From Pompe Disease PatientsWho this might be right forPompe Disease Serhat Gumrukcu, MD PhD 12
Early research (Phase 1)Study completedNCT01239862What this trial is testingSafety of Stem Cells Intrabronchial Instillation for SilicosisWho this might be right forChronic and Accelerated Silicosis Universidade Federal do Rio de Janeiro 5
Testing effectiveness (Phase 2)Looking for participantsNCT05086003What this trial is testingCombined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance InductionWho this might be right forRenal Transplantation Rabin Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT01832441What this trial is testingStudy Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Diabetes Mellitus.Who this might be right forDiabetes Mellitus. Chaitanya Hospital, Pune 100
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1
Very early researchUnknownNCT00434239What this trial is testingLenalidomide and Recombinant Human Stem Cell Factor for Treatment of MyelodysplasiaWho this might be right forMyelodysplasia Peter MacCallum Cancer Centre, Australia 25
Testing effectiveness (Phase 2)Study completedNCT00644241What this trial is testingEfficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus Post Graduate Institute of Medical Education and Research, Chandigarh 10
Testing effectiveness (Phase 2)Study completedNCT01349101What this trial is testingA Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related DonorsWho this might be right forHematological Malignancies Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78
Testing effectiveness (Phase 2)Study completedNCT02569775What this trial is testingOutcomes of Stem Cells for Cerebral PalsyWho this might be right forCerebral Palsy Vinmec Healthcare System 40